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Introduction. West Nile virus (WNV) is a mosquito-transmit-
ted flavivirus widely distributed in Africa, Middle East, Asia, 
Southern Europe and in 1999 was first identified in the United 
States as a cause of disease in New York City. It mainly circulates 
among birds, but can infect many species of mammals. Epidemics 
can occur in rural as well as urban areas.
Methods. 1,280 sera were collected during 2006 from 80 stable 
workers, as jockey and grooms, 100 fowlers, 500 blood donors, 
600 healthcare workers, 100 veterinary surgeons and 100 hunters 
in the Messina province to evaluate the prevalence of the WNV 
infection, by ELISA test, in relation to risk exposure or not.
Results. None of the 1280 subjects examined has shown positive 
for antibodies anti WN virus.
Conclusion. Among the strategies of control and surveillance, 
finally, in our opinion, are and will be indispensable the pro-
grams of continuous antibody survey in all the risk categories 
and in the general population in order to succeed to preview 
which effects could have the presence of infections from WNV, 
also imported from other zones where the virus is constantly 
present, in future and which it could be the impact of geographic 
factors on the epidemic spread of the disease.
Introduction
West nile Virus (WnV), mosquito-borne Flavivirus be-
longing to the Japanese encephalitis antigenic complex 
in the family Flaviviridae, is the most widespread arbo-
virus in the world [1-3] and in the Western hemisphere 
it was detected for the first time in 1999 during an out-
break of encephalitis in new York city [4, 5]. WnV is 
transmitted primarily by the bite of infected mosquitoes 
that acquire the virus by feeding on infected birds [6-8]. 
Data on the incidence of WnV in most of the world are 
not readily available [9]. the ecologic aspects of WnV 
infection, involving mosquitoes, birds, and humans, 
were first described in the 1950s in Egypt [8, 10-12]. the 
agent circulates in nature through continuous enzootic 
transmission cycles between Culicinae mosquitoes and 
avian vertebrate hosts and may be introduced into a new 
territory by migratory birds. humans and horses are 
considered incidental hosts [13, 14]. however, an urban 
cycle with virus amplification by continuous transmis-
sion between birds and vectors, and incidentally, hu-
mans, has been recently described in romania where a 
few cases in the humans are noticed every year and in 
France where recent Wn infections have been detected 
in monitored sentinel birds in 2001 and 2002 [15-18]. 
WnV transmission has been reported in other European 
regions such as Portugal or United Kingdom where the 
virus apparently circulates but doesn’t appear to present 
an imminent threat to human or animals. Many studies 
were done about the prevalence in different countries of 
the old World: Dutchland, Spain, netherlands but no 
evidence of WnV infection has been found in humans 
or horses. in czech republic an imported human case 
of Wn fever (WnF) was recorded in 2002. nine similar 
cases of WnF imported from the USa have already 
been reported in France, Denmark, netherlands and 
germany.
other outbreaks happened in the last decades in the 
Middle East, africa, india, parts of asia, australia (in 
the form of Kunjin virus, a subtype of WnV), north 
america, and parts of central america and caribbean, 
in algeria in 1994, Morocco in 1996, tunisia in 1997 
and 2003, romania in 1996 through 2000, the czech re-
public in 1997, israel in 1999 and 2000, russia in 1999 
through 2001, and France in 2003 [9, 18-21]. Enzootics 
involving horses were reported in Morocco in 1996 and 
2003, italy in 1998, israel in 2000, and Southern France 
in 2000, 2003, and 2004 [18, 22]. Since the virus was 
detected in new York from 1999 through 2004, 16,706 
cases have been reported to the centers for Disease 
control and Prevention (cDc); 7,096 of these were 
classified as neuroinvasive disease, 9,268 as West nile 
Fever (WnF), and 342 had other or unspecified clinical 
presentation (reported through June 8, 2005); the propor-
tion of total cases reported that are neuroinvasive disease 
is actually higher than what is believed to occur naturally 
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since neuroinvasive disease is more likely to be reported 
than WnV or asymptomatic infection. the incidence of 
WnV disease is seasonal in the temperate zones of north 
america, Europe, and the Mediterranean Basin, with 
peak activity from July through october [23, 24]. trans-
mission of WnV in Southern africa and of Kunjin virus 
in australia increases in the early months of the year 
after heavy spring and summer rainfall [25, 26]. the 
most important risk factor for acquiring WnV infection 
is exposure to infected mosquitoes [27]. in romania the 
risk for WnV infection was higher among persons with 
mosquitoes in their homes and with flooded basements 
[28]. an analysis of the locations of WnV disease cases 
during the 1999 outbreak in new York found that cases 
were clustered in an area with higher vegetation cover, 
indicating favourable mosquito habitat [29]. human dis-
ease cases tended to occur in areas with more vegetation, 
older housing, lower population density, predominance 
of older caucasian residents, and proximity to dead 
birds, but the effects of these variables were influenced 
by differences in mosquito abatement efforts [30]. risk 
factors for infection not related to mosquito exposure 
include receiving blood transfusions or organ donations, 
maternal infection during pregnancy or breastfeeding, 
and occupational exposure to the virus [21, 31, 32]. Sta-
tistically, a personal risk of contracting West nile is low, 
and less than 1% of those infected develop serious illness 
from the virus. those at highest risk for serious illness 
are the elderly and those with lowered immune systems. 
however, people of all ages can develop serious illness, 
so it is important for everyone, as mentioned before, to 
protect themselves from mosquito bites to minimize the 
risk of infection. infectious blood components with low 
concentrations of WnV may escape current screening 
tests (cDc 2004) [28]. one instance of possible WnV 
transmission through dialysis has been reported [33]. 
WnV transmission through organ transplantation was 
also first described during the 2002 epidemic [31], more-
over, WnV infection has been occupationally acquired 
by laboratory workers through percutaneous inoculation 
and possibly through aerosol exposure [34, 35]. current-
ly there is not specific drug treatment or vaccine against 
the infection even if there are many experiments to pro-
duce a specific vaccine [36-38]. about italian situation, 
until 1998 no clinical or serological confirmed case of 
Wn disease was ever indicated on national territory [39]. 
however, the doubt that a similar Flavivirus Wn circu-
lated in italy was been marked in the past by serological 
positives verification in human patients and in sheep. the 
fact that the isolated antibodies were never neutralizing 
made the experts think that it was a similar virus but not 
the same. Virus isolation attempts were always negative. 
the first official communication of Wn encephalitis in 
horses bred in tuscany dates back to September 1998. 
the illness began with ataxy to then degenerate in para-
plegy, tetraplegy, coma and death. Usually there was no 
fever. the heald subjects regained normal functions in 
different times spends. on September 20 tuscany began 
a health control that included: the prohibition of moving 
the horses in or out of the area, careful disinfection of the 
stables where deaths occurred. During the outbreak no 
human case was detected while 3.1% of people working 
in these environments showed igg prevalence. on the 
basis of the explained epidemiological data, it is more 
evident that the information about the diffusion of this 
infection in italy are very poor, therefore, in the present 
paper a seroepidemiological study was conducted to de-
fine the prevalence of Wn virus infection among blood 
donors, jockeys, grooms, fowlers, veterinary surgeons 
and hunters in the Messina (italy) area.
Materials and methods
CliniCal samples
1,280 serum specimens were collected during 2006 
from 80 stable workers, as jockey and grooms, 100 
fowlers, 500 blood donors and 600 health work-
ers, 100 veterinary surgeons, and 100 hunters in the 
Messina province to evaluate the infection prevalence 
in relation to risk exposure or not. the samples were 
stored at -80 °c until Elisa test commenced. igg were 
screened to evaluate the circulation of the infection 
into the population in the last two years because they 
could be found after three weeks from infection for at 
least 500 days. on the contrary igM disappear after 
two or three months from the beginning of the disease. 
also, many samples from a non endemic zone were 
tested and it would have been really difficult to found 
igM in samples sera. in case of positivity “Plaque re-
duction neutralization test” will be used to confirm 
the results.
WnV igg enzyme immunoassays
all the samples were tested by igg antibodies against 
WnV by the Focus technologies WnV igg DxSelect 
EliSa where the polystyrene microwells are coated 
with recombinant West nile Virus antigen. testing 
was performed according to the manufacturers’ instruc-
tions: briefly, after bringing all reagents and samples 
to room temperature, we diluted the samples 1:101 in 
Sample Diluent and filled wells with 1X Wash Buffer 
Solution allowing to soak for 5 minutes. in the second 
step we dispensed 100 µl of the sample diluent into the 
“blank” wells, 100 µl of each diluted specimen, control 
or calibrator into the appropriate wells and 100 µl of 
each sample in the remaining 90 wells and incubated 
for 60 minutes at room temperature after covering 
plates or placed in a humid chamber. the third step 
consisted in decanting and washing the plaque three 
times and dispensing 100 µl conjugate to all wells and 
incubating for thirty minutes at room temperature. af-
ter we decanted and washed three times we added 100 
µl of Substrate reagent to all wells and incubated for 
10 minutes. lastly we added 100 µl of Stop reagent 
in the same sequence and at the same pace as the Sub-
strate was added. in antibody-positive wells the colour 
should have changed from blue to yellow. the last step 
was the reading at λ = 450 nm after zeroing the instru-
ment on the blank wells.
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Results and discussion
none of the 1,280 subjects examined for antibodies 
anti Wn virus positive resulted even though different 
categories of subjects (blood donors, operating sanitary, 
jockey and horse grooms, fowlers, veterinary surgeon, 
hunters), who for various reasons could be exposed to 
the infection, were examined. the indisputable data 
have demonstrated the total absence of contact with the 
virus, supporting hypothesis that the outbreak of equine 
encephalomyelitis due to West nile Virus occurred in 
the tuscany region of central italy [20] represented a 
circumscribed phenomenon. Even if, for this purpose, 
it must be remembered that whereas the first isolates 
of WnV were obtained from 1998 in the mentioned 
region, antibodies were detected previously in human 
sera from northern and central italy (1967) and in mi-
gratory birds in northern italy (1973) during the autumn 
migration suggesting that WnV, or a closely related 
arbovirus, has been circulating in italy for decades [39]. 
our data only confirms the total absence of human cases 
in this last decade in our territory, as far as the South of 
italy and Sicily. this is a superimposable situation to 
the other European countries where this kind of study 
were conducted even though sometimes with different 
analysis methodologies as for example in Dutch blood 
donors.
however, this could be related to the fact that italy, 
owing to the outbreak of 1998, has adopted a plan of 
national surveillance in veterinary circles, through the 
04/04/2002 Ministerial ordinance (Mo). then (as a 
result of some seroconversions in horses) the Mo has 
been repeated from the year 2004 until December 31, 
2007 with Decree of the health Ministry (07/13/2005). 
the areas of study were characterized in the plan, spread 
over all the national territory, that for their climatic 
characteristics (humid, swampy, rich zones of aquatic 
birds and high density of bug carriers) can be consid-
ered suitable for the virus introduction and propagation. 
inside these areas the aSl Veterinary Services put into 
effect the surveillance plan that is based essentially in 
the search of the virus in the birds found dead and in the 
bugs, while in the horses and groups of chickens located 
in vicinity of the zones of greater concentration of wild 
bird migration (net of “chickens lookout”), antibodies 
against the agent of the disease are found. all this has 
allowed the activation of a system of alert necessary to 
express eventual previsions in case of virus presence 
in the surveillance area. the surveillance in the human 
population, previewed in the same 04/04/2002 Mo, is 
defined in the circular of the Ministry of the health of 
the 18/09/2002. the prevention of the disease in man is 
essentially based on the fight against mosquitos (insecti-
cide, reclamation acclimatizes them) and in the applica-
tion of protection measures against the bugs, while for 
the animals, apart from the fight against the carriers, a 
vaccine is available (not in italy).
Conclusion
the present study, in conclusion, can be included, in 
the program of control and surveillance of the infec-
tions spread from WnV to our country and supplies an 
effective answer in considering the absence of risk of 
infection in the categories examined. the obtained re-
sults have not suggested abandoning the current effected 
strategy but indeed they want to give a contribution to 
the increment and planning of continuous participation 
turned to the intensification of the efforts to reduce the 
places of reproduction of the mosquitos and to increase 
the application of larvicides in order to kill the grubs 
in those areas in which the virus could be found, repre-
sented by tinning water zones that cannot be completely 
drained. other measures of prevention to intensify 
would be to regularly subject mosquitos and birds to 
the test for the WnV in spring and summer and in the 
case in which the virus is found to levels that indicate a 
threat for human health aimed application of pesticides 
to prevent the infection among the population. in any 
case, it is undoubted that in Europe in the past two dec-
ades there have been a significant number outbreaks in 
several countries. however, very little is known of the 
ecology and natural history of Wn virus transmission in 
Europe and most Wn outbreaks in humans and animals 
remain unpredictable and difficult to control. For this 
reason, among the strategies of control and surveil-
lance, in our opinion, the programs of antibodies survey 
are and will be useful in all the risk categories and in 
the general population in order to predict which effects 
could have the presence of infections from WnV, also 
imported from other zones where the virus is constantly 
present, in future and which could be the geographic 
impact factors on the epidemic spread of the disease
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